PCM
TVGNW icon

Prelude Capital Management’s Tevogen Inc. Warrant TVGNW Stock Holding History

Prelude Capital Management’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24,450
Closed -$7K – 2107
2022
Q1 		$7K Buy
+24,450
New +$9.09K ﹤0.01% 1640

Other funds holding TVGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Prelude Capital Management's TVGNW Position: Q2 2022 in Review

Prelude Capital Management sold out of Tevogen Inc. Warrant (TVGNW) in Q2 2022, closing a stake of 24,450 shares — an estimated $7K sold.

Prelude Capital Management first reported a position in TVGNW in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 46 funds tracked by Wall St. Rank hold TVGNW as of Q2 2022.

  • Prelude Capital Management reported no remaining Tevogen Inc. Warrant position as of Q2 2022 after selling out during the quarter.
  • Prelude Capital Management sold 24,450 Tevogen Inc. Warrant shares in Q2 2022, an estimated $7K.
  • Prelude Capital Management first reported a position in Tevogen Inc. Warrant in Q1 2022 and held it in 1 quarter.
  • Prelude Capital Management's Tevogen Inc. Warrant position peaked at $7K in Q1 2022.
  • 46 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q2 2022.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.